/Investor DB

Morgenthaler — 2015 Investments

3 investments dated 2015 · listed companies and verified rows first · show all

Mulesoftmulesoft.comMay 2015Acquired

MuleSoft is a San Francisco enterprise software company providing integration, API management and automation via its Anypoint Platform.

San Francisco, US

Ross Mason(Founder)inGregory G. Schott(Executive Officer, Director)Matthew Langdon(Executive Officer)Robert Horton(Executive Officer)Michael DiFilippo(Executive Officer)Brent Haywardin

Co-investorsArtisanal VenturesCanvas VenturesCategory VenturesHummer Winblad Venture Partners (HWVP)IVP (Institutional Venture Partners)Lightspeed Venture Partners+13 more

Ra Pharmaceuticalsrapharma.com𝕏Jul 2015

UCB (UCB SA/NV) is a publicly listed biopharmaceutical company focused on research and development of medicines for defined patient populations.

BiotechHealthtechCambridge, US

Douglas A. Treco(Executive Officer, Director)Kerry Black(Executive Officer)inJean-Christophe Tellier(Chief Executive Officer & Chairman of the Executive Committee)Sandrine Dufour(Executive Vice President, Chief Financial Officer)Jean Luc Fleurial(Executive Vice President, Chief Human Resources Officer)Fiona du Monceau(Executive Vice President, Chief Commercial Officer)

Co-investorsLightstone VenturesNew Enterprise Associates (NEA)RA Capital

SetPoint Medicalsetpointmedical.comin𝕏Series C · Sep 2015 · $15M

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)inKevin Tracey(Founder)

BoardBlake Wu(Director)in

Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersAsahi Kasei Corporate Venture CapitalCatalio Capital Management, LP+8 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.